تحميل...
Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs
OBJECTIVES: Researchers studying treatment of coronavirus disease 2019 (COVID-19) have reported findings of randomized trials comparing standard care with care augmented by experimental drugs. Many trials have small sample sizes, so estimates of treatment effects are imprecise. Hence, clinicians may...
محفوظ في:
| الحاوية / القاعدة: | Value Health |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
2021
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7942186/ https://ncbi.nlm.nih.gov/pubmed/33933232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2020.11.019 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|